CytoCalx Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $12.5K

  • Investors
  • 1

CytoCalx General Information

Description

Developer of a biomarker assay designed to estimate the risk and severity of chronic kidney and cardiovascular diseases. The company offers a test that accurately measures active tissue calcification levels in blood samples, enabling healthcare professionals to better assess patient conditions and tailor interventions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Cambridge
  • England, United Kingdom
Primary Industry
Other Healthcare Services
Other Industries
Biotechnology
Other Devices and Supplies
Vertical(s)
Corporate Office
  • Cambridge
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CytoCalx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 16-May-2023 $12.5K Completed Startup
To view CytoCalx’s complete valuation and funding history, request access »

CytoCalx Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Accelerate@Babraham Accelerator/Incubator
To view CytoCalx’s complete investors history, request access »

CytoCalx FAQs

  • When was CytoCalx founded?

    CytoCalx was founded in 2023.

  • Where is CytoCalx headquartered?

    CytoCalx is headquartered in Cambridge, United Kingdom.

  • What industry is CytoCalx in?

    CytoCalx’s primary industry is Other Healthcare Services.

  • Is CytoCalx a private or public company?

    CytoCalx is a Private company.

  • What is CytoCalx’s current revenue?

    The current revenue for CytoCalx is .

  • How much funding has CytoCalx raised over time?

    CytoCalx has raised $12.5K.

  • Who are CytoCalx’s investors?

    Accelerate@Babraham has invested in CytoCalx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process